US Stock MarketDetailed Quotes

EW Edwards Lifesciences

Watchlist
  • 76.190
  • +0.190+0.25%
Close Feb 14 16:00 ET
  • 76.190
  • 0.0000.00%
Post 20:01 ET
44.94BMarket Cap10.93P/E (TTM)

Edwards Lifesciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
-9.41%5.44B
-38.71%1.39B
8.93%1.35B
6.98%1.39B
9.50%1.6B
11.56%6B
67.71%2.26B
-5.73%1.24B
-5.71%1.3B
8.83%1.46B
Operating revenue
-9.41%5.44B
-38.71%1.39B
8.93%1.35B
6.98%1.39B
9.50%1.6B
11.56%6B
67.71%2.26B
-5.73%1.24B
-5.71%1.3B
8.83%1.46B
Cost of revenue
-19.01%1.12B
-55.21%292.2M
4.91%262.9M
11.05%285.3M
17.03%385.6M
27.71%1.38B
152.97%652.4M
-1.26%250.6M
-4.64%256.9M
10.09%329.5M
Gross profit
-6.55%4.32B
-32.02%1.09B
9.94%1.09B
5.97%1.1B
7.30%1.21B
7.51%4.63B
47.54%1.61B
-6.80%992.8M
-5.97%1.04B
8.47%1.13B
Operating expense
-1.88%2.84B
-26.68%740.3M
11.61%697.2M
10.59%723.4M
11.10%774.9M
15.27%2.9B
56.98%1.01B
2.26%624.7M
-0.86%654.1M
16.46%697.5M
Selling and administrative expenses
-1.94%1.79B
-25.32%491.9M
10.34%421.4M
9.84%450.8M
12.24%489.7M
16.39%1.82B
60.27%658.7M
1.22%381.9M
0.34%410.4M
17.82%436.3M
Research and development costs
-1.75%1.05B
-22.76%271.1M
4.37%253.4M
11.86%272.6M
9.19%285.2M
13.39%1.07B
51.16%351M
3.94%242.8M
-2.83%243.7M
14.26%261.2M
Other operating expenses
---300K
---22.7M
--22.4M
----
----
----
----
----
----
----
Operating profit
-14.38%1.48B
-41.03%353.3M
7.12%394.3M
-1.90%377.2M
1.18%437.7M
-3.39%1.73B
33.97%599.1M
-18.97%368.1M
-13.54%384.5M
-2.35%432.6M
Net non-operating interest income expense
102.62%100.5M
163.10%44.2M
60.93%24.3M
70.33%15.5M
91.86%16.5M
204.29%49.6M
112.66%16.8M
118.84%15.1M
911.11%9.1M
1,333.33%8.6M
Non-operating interest income
----
----
60.93%24.3M
70.33%15.5M
----
89.30%67.2M
--34.4M
--15.1M
--9.1M
----
Non-operating interest expense
----
----
----
----
----
-8.33%17.6M
----
----
----
----
Total other finance cost
---100.5M
---44.2M
----
----
-91.86%-16.5M
----
----
----
----
---8.6M
Other net income (expense)
81.95%-32.5M
67.83%-7.4M
-459.09%-15.8M
94.85%-6.1M
-5.16%-44.8M
-372.70%-180.1M
-647.62%-23M
108.16%4.4M
-720.42%-118.5M
-468.00%-42.6M
Gain on sale of security
----
----
----
----
----
526.09%9.8M
----
----
----
----
Special income (charges)
47.87%-101.4M
-50.18%-40.7M
-1,886.36%-43.7M
93.31%-8.1M
-13.57%-50.2M
-427.10%-194.5M
-715.91%-27.1M
95.76%-2.2M
-750.54%-121M
-952.38%-44.2M
-Less：Restructuring and merger&acquisition
777.78%61M
63.37%28.1M
--32.9M
--0
5,800.00%41.3M
-136.14%-9M
-71.90%17.2M
--0
-28.71%-26.9M
124.14%700K
-Less:Other special charges
-80.15%40.4M
27.27%12.6M
390.91%10.8M
-94.52%8.1M
-79.54%8.9M
1,595.83%203.5M
115.09%9.9M
-96.58%2.2M
6,330.43%147.9M
512.68%43.5M
Other non- operating income (expenses)
1,397.83%68.9M
684.21%33.3M
322.73%27.9M
-20.00%2M
237.50%5.4M
318.18%4.6M
-371.43%-5.7M
430.00%6.6M
66.67%2.5M
1,500.00%1.6M
Income before tax
-3.13%1.55B
-34.20%390.1M
3.92%402.8M
40.53%386.6M
2.71%409.4M
-9.58%1.6B
29.09%592.9M
-4.84%387.6M
-40.80%275.1M
-8.60%398.6M
Income tax
-23.45%152.1M
-43.91%45.1M
-22.77%40.7M
-3.35%20.2M
0.52%58.4M
-19.06%198.7M
32.02%80.4M
-17.40%52.7M
-64.15%20.9M
-7.04%58.1M
Net income
197.96%4.17B
3.95%384.3M
699.95%3.07B
19.48%365M
3.08%351M
-8.05%1.4B
-7.20%369.7M
11.70%383.7M
-24.83%305.5M
-8.86%340.5M
Net income continuous Operations
-0.24%1.4B
-32.68%345M
8.12%362.1M
44.14%366.4M
3.08%351M
-8.05%1.4B
28.64%512.5M
-2.50%334.9M
-37.45%254.2M
-8.86%340.5M
Net income discontinuous operations
--2.77B
--39.3M
5,447.75%2.71B
-102.73%-1.4M
----
----
----
--48.8M
--51.3M
----
Minority interest income
-63.33%-4.9M
-550.00%-1.3M
-16.67%-1.4M
18.75%-1.3M
-900K
-3M
-200K
-1.2M
-1.6M
0
Net income attributable to the parent company
197.68%4.17B
4.24%385.6M
697.82%3.07B
19.28%366.3M
3.35%351.9M
-7.85%1.4B
-7.15%369.9M
12.05%384.9M
-24.43%307.1M
-8.86%340.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
197.68%4.17B
4.24%385.6M
697.82%3.07B
19.28%366.3M
3.35%351.9M
-7.85%1.4B
-7.15%369.9M
12.05%384.9M
-24.43%307.1M
-8.86%340.5M
Basic earnings per share
202.16%6.98
6.56%0.65
715.87%5.14
19.61%0.61
3.57%0.58
-6.10%2.31
-6.15%0.61
14.55%0.63
-21.54%0.51
-6.67%0.56
Diluted earnings per share
203.04%6.97
6.56%0.65
714.29%5.13
22.00%0.61
3.57%0.58
-5.74%2.3
-6.15%0.61
14.55%0.63
-23.08%0.5
-5.08%0.56
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue -9.41%5.44B-38.71%1.39B8.93%1.35B6.98%1.39B9.50%1.6B11.56%6B67.71%2.26B-5.73%1.24B-5.71%1.3B8.83%1.46B
Operating revenue -9.41%5.44B-38.71%1.39B8.93%1.35B6.98%1.39B9.50%1.6B11.56%6B67.71%2.26B-5.73%1.24B-5.71%1.3B8.83%1.46B
Cost of revenue -19.01%1.12B-55.21%292.2M4.91%262.9M11.05%285.3M17.03%385.6M27.71%1.38B152.97%652.4M-1.26%250.6M-4.64%256.9M10.09%329.5M
Gross profit -6.55%4.32B-32.02%1.09B9.94%1.09B5.97%1.1B7.30%1.21B7.51%4.63B47.54%1.61B-6.80%992.8M-5.97%1.04B8.47%1.13B
Operating expense -1.88%2.84B-26.68%740.3M11.61%697.2M10.59%723.4M11.10%774.9M15.27%2.9B56.98%1.01B2.26%624.7M-0.86%654.1M16.46%697.5M
Selling and administrative expenses -1.94%1.79B-25.32%491.9M10.34%421.4M9.84%450.8M12.24%489.7M16.39%1.82B60.27%658.7M1.22%381.9M0.34%410.4M17.82%436.3M
Research and development costs -1.75%1.05B-22.76%271.1M4.37%253.4M11.86%272.6M9.19%285.2M13.39%1.07B51.16%351M3.94%242.8M-2.83%243.7M14.26%261.2M
Other operating expenses ---300K---22.7M--22.4M----------------------------
Operating profit -14.38%1.48B-41.03%353.3M7.12%394.3M-1.90%377.2M1.18%437.7M-3.39%1.73B33.97%599.1M-18.97%368.1M-13.54%384.5M-2.35%432.6M
Net non-operating interest income expense 102.62%100.5M163.10%44.2M60.93%24.3M70.33%15.5M91.86%16.5M204.29%49.6M112.66%16.8M118.84%15.1M911.11%9.1M1,333.33%8.6M
Non-operating interest income --------60.93%24.3M70.33%15.5M----89.30%67.2M--34.4M--15.1M--9.1M----
Non-operating interest expense ---------------------8.33%17.6M----------------
Total other finance cost ---100.5M---44.2M---------91.86%-16.5M-------------------8.6M
Other net income (expense) 81.95%-32.5M67.83%-7.4M-459.09%-15.8M94.85%-6.1M-5.16%-44.8M-372.70%-180.1M-647.62%-23M108.16%4.4M-720.42%-118.5M-468.00%-42.6M
Gain on sale of security --------------------526.09%9.8M----------------
Special income (charges) 47.87%-101.4M-50.18%-40.7M-1,886.36%-43.7M93.31%-8.1M-13.57%-50.2M-427.10%-194.5M-715.91%-27.1M95.76%-2.2M-750.54%-121M-952.38%-44.2M
-Less：Restructuring and merger&acquisition 777.78%61M63.37%28.1M--32.9M--05,800.00%41.3M-136.14%-9M-71.90%17.2M--0-28.71%-26.9M124.14%700K
-Less:Other special charges -80.15%40.4M27.27%12.6M390.91%10.8M-94.52%8.1M-79.54%8.9M1,595.83%203.5M115.09%9.9M-96.58%2.2M6,330.43%147.9M512.68%43.5M
Other non- operating income (expenses) 1,397.83%68.9M684.21%33.3M322.73%27.9M-20.00%2M237.50%5.4M318.18%4.6M-371.43%-5.7M430.00%6.6M66.67%2.5M1,500.00%1.6M
Income before tax -3.13%1.55B-34.20%390.1M3.92%402.8M40.53%386.6M2.71%409.4M-9.58%1.6B29.09%592.9M-4.84%387.6M-40.80%275.1M-8.60%398.6M
Income tax -23.45%152.1M-43.91%45.1M-22.77%40.7M-3.35%20.2M0.52%58.4M-19.06%198.7M32.02%80.4M-17.40%52.7M-64.15%20.9M-7.04%58.1M
Net income 197.96%4.17B3.95%384.3M699.95%3.07B19.48%365M3.08%351M-8.05%1.4B-7.20%369.7M11.70%383.7M-24.83%305.5M-8.86%340.5M
Net income continuous Operations -0.24%1.4B-32.68%345M8.12%362.1M44.14%366.4M3.08%351M-8.05%1.4B28.64%512.5M-2.50%334.9M-37.45%254.2M-8.86%340.5M
Net income discontinuous operations --2.77B--39.3M5,447.75%2.71B-102.73%-1.4M--------------48.8M--51.3M----
Minority interest income -63.33%-4.9M-550.00%-1.3M-16.67%-1.4M18.75%-1.3M-900K-3M-200K-1.2M-1.6M0
Net income attributable to the parent company 197.68%4.17B4.24%385.6M697.82%3.07B19.28%366.3M3.35%351.9M-7.85%1.4B-7.15%369.9M12.05%384.9M-24.43%307.1M-8.86%340.5M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 197.68%4.17B4.24%385.6M697.82%3.07B19.28%366.3M3.35%351.9M-7.85%1.4B-7.15%369.9M12.05%384.9M-24.43%307.1M-8.86%340.5M
Basic earnings per share 202.16%6.986.56%0.65715.87%5.1419.61%0.613.57%0.58-6.10%2.31-6.15%0.6114.55%0.63-21.54%0.51-6.67%0.56
Diluted earnings per share 203.04%6.976.56%0.65714.29%5.1322.00%0.613.57%0.58-5.74%2.3-6.15%0.6114.55%0.63-23.08%0.5-5.08%0.56
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
XINGANJIANG
873167
+30.00%
INNOVATIVE DATA
835305
+29.98%
CHENGUANG MEDICAL
430300
+29.96%
4
Hangzhou Gaoxin Materials Technology
300478
+20.04%
5
Beijing Philisense Technology
300287
+20.03%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More
FOMC Press Conference, January 29, 2025